NDC 0591-0791-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-0791
- Requested NDC
- 0591-0791-01
- Package NDCs from labels
- 0591-0791-01, 0591-0791-05
- Manufacturer
- Watson Labs
- Effective date
- 2007-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Watson Labs | Watson Labs | 2007-02-06 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-0791-01 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 0591-0791-05 | Naproxen | 500 in 1 BOTTLE | TABLET | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Naproxen | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Naproxen | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Croscarmellose sodium | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Povidone | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic black iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic red iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic yellow iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 71d4a048-ca50-73db-e053-2a95a90ad465 | 2024-06-10 | Warnings | 198013 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 69366b55-2687-17a4-e053-2a91aa0a65b3 | 2024-06-07 | 198014 | |
| Naproxen | NAPROXEN | Advanced Rx Pharmacy of Tennessee, LLC | 1431b769-5535-78d6-e063-6394a90a8423 | 2024-03-21 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Asclemed USA, Inc. | 5a48c0d4-37bf-4c26-a9a7-5c67ff2adb4b | 2024-03-19 | Boxed warning, Warnings, Adverse reactions | 198013 198012 |
| Naproxen | NAPROXEN | Medsource Pharmaceuticals | 12648efc-3be8-a915-e063-6394a90a3620 | 2024-02-27 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 1cdcaba5-5550-40f6-94cc-b0a98cc17d3c | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | d564f52d-171c-4e7d-974c-3a0e192e6c12 | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | f91c1a6b-b256-42e1-9da0-5f1975dec6ce | 2023-12-27 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | a8b54258-84e7-41e8-9e51-137a3f442e6b | 2023-10-23 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 80233fa5-f8b4-42d5-a8c9-4a1d8fd4aba4 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 50c52976-9e04-4a5e-9f21-aca3ea5c2924 | 2023-09-06 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | d801ba16-e2ec-4bb2-8cff-32388634b35a | 2023-09-06 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 21930f73-d3c2-4462-a487-74ed871b74b2 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 198013 |
| Naproxen | NAPROXEN | A-S Medication Solutions | a5ea3a84-7acd-4f24-9f0f-9f871ce1b5f4 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 198012 |
| naproxen | NAPROXEN | Cipla USA Inc. | a9549a47-3fa4-4a2b-95ac-b00e43aedae7 | 2023-01-18 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| Naproxen | NAPROXEN | Proficient Rx LP | d0670241-f1f9-4fdf-83d4-547e7b800811 | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | 198014 |
| NAPROXEN | NAPROXEN | Asclemed USA, Inc. | a4fcb411-c918-459b-adc6-06dfa8ed8a50 | 2022-10-12 | Warnings | 198014 |
| Naproxen | NAPROXEN | Proficient Rx LP | aa4d159c-9cbe-4d29-9532-33a312f1ae05 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 198013 |
| Naproxen | NAPROXEN | Proficient Rx LP | 96601d76-50ea-4dc0-b588-d174f8d8bb51 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | 98efdeb8-ea38-456e-953f-ba589727f284 | 2021-11-10 | Boxed warning, Warnings, Adverse reactions | 198014 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.